-
1 week ago | 
today.westlaw.com | Puyaan Singh |Shilpi Majumdar |Krishna Eluri
(Reuters) - The U.S. Food and Drug Administration said on Thursday all its centers will deploy artificial intelligence internally immediately, with full integration on June 30, following the completion of a new generative AI pilot for scientific...
-
2 weeks ago | 
marketscreener.com | Christy Santhosh |Puyaan Singh
(Reuters) -AbbVie raised its full-year profit forecast on Friday while downplaying the potential hit some analysts expect it to take from sector-specific import duties that could be imposed by the Trump administration. Drugmaker shares, including AbbVie's, have fallen over the past month due to investor concerns around a probe into pharmaceutical imports that sets the stage for U.S. levies on the sector.
-
2 weeks ago | 
yahoo.com | Christy Santhosh |Puyaan Singh
By Christy Santhosh and Puyaan Singh(Reuters) -AbbVie raised its 2025 profit forecast on Friday after strong sales of its newer immunology drugs Skyrizi and Rinvoq helped the company beat Wall Street estimates for first-quarter earnings, sending shares up more than 4% in premarket trading. The company said its updated forecast did not reflect any trade policy shifts, including possible U.S. tariffs on the pharmaceutical sector.
-
4 weeks ago | 
marketscreener.com | Christy Santhosh |Puyaan Singh
(Reuters) -Medical device maker Abbott Laboratories maintained its annual profit forecast on Wednesday and said it expected the U.S. tariffs to hit earnings by a "few hundred million dollars". Shares rose 6% in morning trade, as the company also announced $500 million in new investments in manufacturing and research projects in Illinois and Texas.
-
1 month ago | 
reuters.com | Puyaan Singh
The Centers for Medicare & Medicaid Services said on Friday it did not move forward with a proposal put forth by the Biden administration for Medicare coverage of weight-loss drugs such as Novo Nordisk's Wegovy.
-
1 month ago | 
terra.com.br | Puyaan Singh
Os Centros de Serviços Medicare e Medicaid (CMS) disseram nesta sexta-feira que não avançaram com a proposta apresentada pelo governo Biden de o Medicare cobrir medicamentos para perda de peso como o Wegovy, da Novo Nordisk. As ações da Novo, listadas nos EUA, caíram 1,4% nas negociações pós-mercado, enquanto as da Eli Lilly, que fabrica o medicamento para obesidade Zepbound, caíram 3,1%.
-
1 month ago | 
ca.news.yahoo.com | Puyaan Singh
(Reuters) - The Centers for Medicare & Medicaid Services said on Friday it did not move forward with a proposal put forth by the Biden administration for Medicare coverage of weight-loss drugs such as Novo Nordisk's Wegovy. U.S.-listed shares of Novo fell 1.4% in aftermarket trading, while those of Eli Lilly, which makes obesity drug Zepbound, were down 3.1%.
-
1 month ago | 
uk.marketscreener.com | Puyaan Singh
(Reuters) -The Texas Department of State Health Services on Friday reported 59 new measles cases in three days, bringing the total to 481 in the state, while New Mexico's health department reported 54 infections, adding six, as the disease spreads across the country. Cases in Gaines County, the center of the outbreak, rose to 315 from 280 on April 1, Texas' health department said. Hospitalizations rose to 56 from 42.
-
1 month ago | 
gazette.com | Puyaan Singh
By Puyaan Singh(Reuters) -The Texas Department of State Health Services on Friday reported 59 new measles cases in three days, bringing the total to 481 in the state, while New Mexico's health department reported 54 infections, adding six, as the disease spreads across the country. Cases in Gaines County, the center of the outbreak, rose to 315 from 280 on April 1, Texas' health department said. Hospitalizations rose to 56 from 42.
-
1 month ago | 
today.westlaw.com | Puyaan Singh |Shinjini Ganguli
(Reuters) - The Centers for Medicare & Medicaid Services said on Friday it did not move forward with a proposal put forth by the Biden administration for Medicare coverage of...
